Yamashita K, Kataoka Y, Nakashima M N, Yamashita Y S, Tanabe H, Araki H, Niwa M, Taniyama K
Department of Pharmacology, Nagasaki University School of Medicine, Japan.
Jpn J Pharmacol. 1996 Aug;71(4):351-5. doi: 10.1254/jjp.71.351.
TTC-909 is a newly developed isocarbacyclin methyl ester (TEI-9090) incorporated in lipid microspheres. The neuroprotective effect of TTC-909 was histologically examined in the pyramidal cell layer of the hippocampus CA1 subfield 7 days after transient forebrain ischemia using stroke-prone spontaneously hypertensive rats. TTC-909, given intravenously 10 min after the transient forebrain ischemia, dose-dependently protected against ischemia-related delayed neuronal death. The blood pressure remained unchanged following TTC-909 administration. This finding suggests that TTC-909 has a neuroprotective action on ischemic delayed neuronal death in the hippocampus.
TTC - 909是一种新开发的、包裹于脂质微球中的异前列腺素甲酯(TEI - 9090)。使用易患中风的自发性高血压大鼠,在短暂性前脑缺血7天后,对海马CA1亚区锥体细胞层进行组织学检查,以研究TTC - 909的神经保护作用。在短暂性前脑缺血后10分钟静脉注射TTC - 909,其对缺血相关的迟发性神经元死亡具有剂量依赖性保护作用。给予TTC - 909后血压保持不变。这一发现表明,TTC - 909对海马区缺血性迟发性神经元死亡具有神经保护作用。